Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Leader in true multi-omic spatial sequencing
Peijia Medical is an interventional medical products provider
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.
NuVera Medical is a medical device company
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer.
Hitales is an internet company that develops applications of medical artificial intelligence products.
360 Health provide health care and life science services to clients in China.
Lilly Asia Ventures has invested in 105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lilly Asia Ventures's top investment sectors include Biotechnology, Medical, Health Care, Pharmaceutical, Medical Device. The firm invests across 16 different industry categories.
Among tracked funding rounds, Peijia Medical received $100.0M in a Series C round. Lilly Asia Ventures's total known invested capital is $8.3B.
Lilly Asia Ventures's average investment size is $105.9M across its portfolio of 105 companies.
Recent Lilly Asia Ventures portfolio additions include ReadCoor. These companies were founded in 2020 or later.